Adient Financials
Adient (ADNT) reported $14.5B in revenue for fiscal year 2025, down 1.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Adient runs on very thin gross margins, so working-capital discipline matters as much as the income statement.
From FY2023 to FY2025, inventory fell from$841M to$695M even as revenue softened, showing the balance sheet was being tightened rather than expanded to support sales. That matters because FY2025 still converted a net loss of-$281M into free cash flow of$204M , so recent cash resilience came more from working-capital release than from a wide margin cushion.
The balance sheet is more leveraged through shrinking equity than through new borrowing: long-term debt stayed near
With gross margin at just
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Adient's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Adient, and counted as zero in the overall score.
Adient's revenue declined 1.0% year-over-year, from $14.7B to $14.5B. This contraction results in a growth score of 22/100.
Adient has a moderate D/E ratio of 1.35. This balance of debt and equity financing earns a leverage score of 39/100.
Adient's current ratio of 1.12 is below the typical benchmark, resulting in a score of 25/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Adient has a free cash flow margin of 1.4%, earning a moderate score of 35/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Adient, and counted as zero in the overall score.
Adient passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Adient reported a net loss of $281.0M while generating $449.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Adient generated $14.5B in revenue in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Adient reported -$281.0M in net income in fiscal year 2025. This represents a decrease of 1661.1% from the prior year.
Adient earned -$3.39 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1795.0% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Adient generated $204.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 26.4% from the prior year.
Adient held $958.0M in cash against $2.4B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Adient's gross margin was 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Adient's net profit margin was -1.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.1 percentage points from the prior year.
Adient's ROE was -15.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 16.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Adient invested $387.0M in research and development in fiscal year 2025. This represents an increase of 4.0% from the prior year.
Adient spent $125.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 54.5% from the prior year.
Adient invested $245.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.9% from the prior year.
ADNT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.1B | $14.5B-1.0% | $14.7B-4.6% | $15.4B+9.0% | $14.1B+3.2% | $13.7B+8.0% | $12.7B-23.3% | $16.5B-5.2% | $17.4B+7.6% | $16.2B-3.4% | $16.8B-16.1% | $20.0B |
| Cost of Revenue | $14.2B | $13.6B-1.4% | $13.8B-4.2% | $14.4B+7.9% | $13.3B+3.6% | $12.9B+6.4% | $12.1B-23.2% | $15.7B-4.9% | $16.5B+11.7% | $14.8B-2.5% | $15.2B-16.5% | $18.2B |
| Gross Profit | $956.0M | $961.0M+3.6% | $928.0M-10.2% | $1.0B+28.0% | $807.0M-2.3% | $826.0M+39.5% | $592.0M-26.1% | $801.0M-11.4% | $904.0M-35.3% | $1.4B-13.2% | $1.6B-13.1% | $1.9B |
| R&D Expenses | N/A | $387.0M+4.0% | $372.0M+2.8% | $362.0M+12.4% | $322.0M+1.9% | $316.0M-14.6% | $370.0M-18.5% | $454.0M-11.5% | $513.0M+5.1% | $488.0M+6.1% | $460.0M-23.2% | $599.0M |
| SG&A Expenses | $528.0M | $522.0M+3.0% | $507.0M-8.5% | $554.0M-7.4% | $598.0M+11.4% | $537.0M-3.8% | $558.0M-16.8% | $671.0M-8.1% | $730.0M+0.1% | $729.0M-40.3% | $1.2B+8.0% | $1.1B |
| Interest Expense | $187.0M | $183.0M-2.1% | $187.0M+41.7% | $132.0M-31.3% | $192.0M-16.2% | $229.0M+12.8% | $203.0M+48.2% | $137.0M-4.2% | $143.0M+10.9% | $129.0M+2480.0% | $5.0M+141.7% | -$12.0M |
| Income Tax | $123.0M | $103.0M+221.9% | $32.0M | $0-100.0% | $94.0M-62.2% | $249.0M+336.8% | $57.0M-86.1% | $410.0M-14.6% | $480.0M+384.8% | $99.0M-94.6% | $1.8B+340.0% | $418.0M |
| Net Income | $48.0M | -$281.0M-1661.1% | $18.0M-91.2% | $205.0M+270.8% | -$120.0M-110.8% | $1.1B+302.6% | -$547.0M-11.4% | -$491.0M+70.9% | -$1.7B-292.1% | $877.0M+156.7% | -$1.5B-436.1% | $460.0M |
| EPS (Diluted) | — | -$3.39-1795.0% | $0.20-90.7% | $2.15+269.3% | -$1.27-111.0% | $11.58+298.6% | -$5.83-11.0% | -$5.25+70.9% | -$18.06-293.4% | $9.34+156.6% | -$16.50-436.7% | $4.90 |
Not reported in any period shown, so not listed: Operating Income.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
ADNT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B-4.2% | $9.4B-0.8% | $9.4B+2.9% | $9.2B-15.0% | $10.8B+5.0% | $10.3B-0.8% | $10.3B-5.5% | $10.9B-16.9% | $13.2B+1.7% | $13.0B+24.4% | $10.4B |
| Current Assets | $4.1B+1.2% | $4.1B-5.3% | $4.3B+3.7% | $4.2B-18.1% | $5.1B+13.5% | $4.5B+8.9% | $4.1B-4.5% | $4.3B-4.2% | $4.5B-20.9% | $5.7B | N/A |
| Cash & Equivalents | $958.0M+1.4% | $945.0M-14.9% | $1.1B+17.2% | $947.0M-37.7% | $1.5B-10.1% | $1.7B+83.1% | $924.0M+34.5% | $687.0M-3.1% | $709.0M+575.2% | $105.0M+138.6% | $44.0M |
| Inventory | $695.0M-8.3% | $758.0M-9.9% | $841.0M-11.8% | $953.0M-2.4% | $976.0M+42.5% | $685.0M-13.6% | $793.0M-3.8% | $824.0M+12.1% | $735.0M+11.4% | $660.0M | N/A |
| Goodwill | $1.8B-16.5% | $2.2B+3.3% | $2.1B+1.8% | $2.1B-7.0% | $2.2B+7.5% | $2.1B-4.3% | $2.1B-1.5% | $2.2B-13.2% | $2.5B+15.4% | $2.2B+0.9% | $2.2B |
| Total Liabilities | $7.2B-0.4% | $7.2B+0.3% | $7.2B+1.6% | $7.1B-15.7% | $8.4B-7.1% | $9.0B+6.5% | $8.5B-0.7% | $8.6B-3.8% | $8.9B+1.3% | $8.8B+88.0% | $4.7B |
| Current Liabilities | $3.7B+0.2% | $3.7B-1.6% | $3.7B+6.8% | $3.5B-0.3% | $3.5B-8.1% | $3.8B-0.4% | $3.8B-8.5% | $4.2B-3.1% | $4.3B+1.6% | $4.3B | N/A |
| Long-Term Debt | $2.4B-0.4% | $2.4B-0.2% | $2.4B-6.4% | $2.6B-27.0% | $3.5B-14.3% | $4.1B+10.5% | $3.7B+8.4% | $3.4B-0.5% | $3.4B-0.1% | $3.4B | N/A |
| Total Equity | $1.8B-17.2% | $2.1B-4.2% | $2.2B+7.5% | $2.1B-12.8% | $2.4B+95.9% | $1.2B-34.4% | $1.8B-22.7% | $2.4B-44.1% | $4.3B+2.5% | $4.2B-27.3% | $5.7B |
| Retained Earnings | -$1.2B-31.8% | -$885.0M+2.0% | -$903.0M+18.5% | -$1.1B-12.1% | -$988.0M+52.9% | -$2.1B-35.7% | -$1.5B-50.3% | -$1.0B-240.1% | $734.0M | $0 | N/A |
Not reported in any period shown, so not listed: Accounts Receivable.
ADNT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $579.0M | $449.0M-17.3% | $543.0M-18.6% | $667.0M+143.4% | $274.0M+5.4% | $260.0M+5.7% | $246.0M-20.1% | $308.0M-54.6% | $679.0M-9.0% | $746.0M+172.1% | -$1.0B-360.5% | $397.0M |
| Capital Expenditures | $284.0M | $245.0M-7.9% | $266.0M+5.6% | $252.0M+11.0% | $227.0M-12.7% | $260.0M-20.2% | $326.0M-30.3% | $468.0M-12.7% | $536.0M-7.1% | $577.0M+32.0% | $437.0M-8.6% | $478.0M |
| Free Cash Flow | $295.0M | $204.0M-26.4% | $277.0M-33.3% | $415.0M+783.0% | $47.0M | $0+100.0% | -$80.0M+50.0% | -$160.0M-211.9% | $143.0M-15.4% | $169.0M+111.5% | -$1.5B-1716.0% | -$81.0M |
| Investing Cash Flow | -$264.0M | -$186.0M+26.5% | -$253.0M-10.5% | -$229.0M-147.3% | $484.0M+39.5% | $347.0M+109.0% | $166.0M+143.3% | -$383.0M+21.4% | -$487.0M+38.7% | -$795.0M-87.1% | -$425.0M+13.1% | -$489.0M |
| Financing Cash Flow | -$218.0M | -$267.0M+46.8% | -$502.0M-85.2% | -$271.0M+78.7% | -$1.3B-65.3% | -$770.0M-295.9% | $393.0M+29.7% | $303.0M+242.3% | -$213.0M-134.0% | $627.0M-58.6% | $1.5B+1530.1% | $93.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $26.0M-74.8% | $103.0M+98.1% | $52.0M | $0 | $0 |
| Share Buybacks | $105.0M | $125.0M-54.5% | $275.0M+323.1% | $65.0M | $0 | $0 | N/A | $0 | $0-100.0% | $40.0M | $0 | $0 |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
ADNT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 6.6%+0.3pp | 6.3%-0.4pp | 6.7%+1.0pp | 5.7%-0.3pp | 6.0%+1.4pp | 4.7%-0.2pp | 4.9%-0.3pp | 5.2%-3.4pp | 8.6%-1.0pp | 9.6%+0.3pp | 9.3% |
| Net Margin | -1.9%-2.1pp | 0.1%-1.2pp | 1.3%+2.2pp | -0.9%-8.9pp | 8.1%+12.4pp | -4.3%-1.4pp | -3.0%+6.7pp | -9.7%-15.1pp | 5.4%+14.6pp | -9.2%-11.5pp | 2.3% |
| Return on Equity | -15.9%-16.8pp | 0.8%-8.4pp | 9.2%+15.0pp | -5.8%-52.4pp | 46.6%+91.7pp | -45.1%-18.5pp | -26.6%+43.9pp | -70.4%-90.9pp | 20.5%+57.5pp | -37.0%-45.0pp | 8.0% |
| Return on Assets | -3.1%-3.3pp | 0.2%-2.0pp | 2.2%+3.5pp | -1.3%-11.6pp | 10.3%+15.6pp | -5.3%-0.6pp | -4.8%+10.7pp | -15.4%-22.1pp | 6.7%+18.6pp | -11.9%-16.4pp | 4.4% |
| Current Ratio | 1.120.0x | 1.110.0x | 1.150.0x | 1.19-0.3x | 1.45+0.3x | 1.17+0.1x | 1.070.0x | 1.030.0x | 1.04-0.3x | 1.34 | N/A |
| Debt-to-Equity | 1.35+0.2x | 1.120.0x | 1.08-0.2x | 1.24-0.2x | 1.48-1.9x | 3.38+1.4x | 2.01+0.6x | 1.43+0.6x | 0.800.0x | 0.820.0x | 0.81 |
| FCF Margin | 1.4%-0.5pp | 1.9%-0.8pp | 2.7%+2.4pp | 0.3%+0.3pp | 0.0%+0.6pp | -0.6%+0.3pp | -1.0%-1.8pp | 0.8%-0.2pp | 1.0%+9.8pp | -8.8%-8.4pp | -0.4% |
Not reported in any period shown, so not listed: Operating Margin.
Similar Companies
Where Adient Ranks
Frequently Asked Questions
What is Adient's annual revenue?
Adient (ADNT) reported $14.5B in total revenue for fiscal year 2025. This represents a -1.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Adient's revenue growing?
Adient (ADNT) revenue declined by 1.0% year-over-year, from $14.7B to $14.5B in fiscal year 2025.
Is Adient profitable?
No, Adient (ADNT) reported a net income of -$281.0M in fiscal year 2025, with a net profit margin of -1.9%.
How much debt does Adient have?
As of fiscal year 2025, Adient (ADNT) had $958.0M in cash and equivalents against $2.4B in long-term debt.
What is Adient's gross margin?
Adient (ADNT) had a gross margin of 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Adient's net profit margin?
Adient (ADNT) had a net profit margin of -1.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Adient's return on equity (ROE)?
Adient (ADNT) has a return on equity of -15.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Adient's free cash flow?
Adient (ADNT) generated $204.0M in free cash flow during fiscal year 2025. This represents a -26.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Adient's operating cash flow?
Adient (ADNT) generated $449.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Adient's total assets?
Adient (ADNT) had $9.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Adient's capital expenditures?
Adient (ADNT) invested $245.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Adient spend on research and development?
Adient (ADNT) invested $387.0M in research and development during fiscal year 2025.
What is Adient's current ratio?
Adient (ADNT) had a current ratio of 1.12 as of fiscal year 2025, which is considered adequate.
What is Adient's debt-to-equity ratio?
Adient (ADNT) had a debt-to-equity ratio of 1.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Adient's return on assets (ROA)?
Adient (ADNT) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Adient's Piotroski F-Score?
Adient (ADNT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Adient's earnings high quality?
Adient (ADNT) reported a net loss of $281.0M while generating $449.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Adient?
Adient (ADNT) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.